MJNA News Alert Medical Marijuana I (MJNA) 0.1140 10/01/2014

New Post Public Reply Private Reply Replies (0) Message Board

Oct 1, 2014 at 3:44 AM

Medical Marijuana I (MJNA) 0.1140 $MJNA

NTRR Partner Vertigo Technologies Acquires Turn-Key Horticulture Operation
Business Wire - Mon Sep 29, 4:00AM CDT
As the $2.3 billion legal cannabis market in the U.S. continues to grow, all-natural wellness provider Neutra Corp. (OTCBB:NTRR) and its joint venture partner Vertigo Technologies, Inc., took a big step toward revolutionizing indoor growing operations across the country this week.

Enertopia Submits MMPR Application For Burlington JV & Builds Awareness
ACCESSWIRE - Wed Sep 24, 9:46AM CDT
Whitefish, MT / September 24, 2014 / Enertopia Corp., (OTC: ENRT) an aspiring Licensed Producer of medical marijuana under Canada's Marihuana for Medical Purposes Regulations ("MMPR"

program, recently announced progress across two of its projects and new efforts to raise awareness among both physicians and consumers within an industry that Health Canada expects to reach C$1.3 billion by 2024.

NTRR: 'Reciprocity' Could Pay Big Dividends in Cannabis Market
Business Wire - Tue Sep 23, 8:27AM CDT
A new experiment in Nevada could pay big dividends for Neutra Corp. (OTCBB: NTRR) and others preparing products for the booming U.S. cannabis industry and ancillary markets.

Photo Release -- aNew Day for Hemp: Medical Marijuana Inc.'s HempMeds Launches CBD-Rich Functional Foods at Expo East
GlobeNewswire - Fri Sep 19, 12:36PM CDT
Medical Marijuana Inc.'s (OTC Pink:MJNA) HempMeds(TM) - a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for Medical Marijuana, Inc. - announced from Expo East significant advances for both the cannabis and natural products industry with the public launch of its cannabidiol (CBD)-rich hemp oil infused natural products retail and pet nutrition lines: aNew Brands.

Cannabis for Consumers ... and Pets: Medical Marijuana Inc.'s HempMeds Unveils New CBD-Rich Products at Natural Products Expo East
GlobeNewswire - Tue Sep 16, 12:39PM CDT
Medical Marijuana Inc.'s (OTC Pink:MJNA) HempMeds(TM) - a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for Medical Marijuana, Inc. - is proud to sponsor Natural Products Expo East. HempMeds(TM), a pioneer of cannabidiol (CBD)-rich (hemp) cannabis products, is exhibiting from booth #4215 and will reach an estimated 25,000 natural product buyers during the two-day expo.

Market Maker Surveillance Report. BAC, GILD, EMC, S, NIHD, MJNA, Highest Net Sell Volume and Negative Price Friction For Monday, September 15th 2014
M2 - Tue Sep 16, 5:59AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4654 companies with "abnormal" market making, 1512 companies with positive Friction Factors and 3686 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Monday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. BANK OF AMERICA CORPORATION (NYSE:BAC), GILEAD SCIENCES, INC. (NASDAQ:GILD), EMC Corp (NYSE:EMC), Sprint Nextel Corp (NYSE:S), NII Holdings Inc (NASDAQ:NIHD), Medical Marijuana Inc (OTC:MJNA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

NTRR Conducts First Tests on Pesticide-Free Horticulture Treatment
Business Wire - Tue Sep 16, 4:00AM CDT
Neutra Corp. (OTCBB:NTRR), an all-natural wellness solutions company, announced today that its joint venture partner Surface to Air Solutions (S2O2) has completed successful initial testing on a new antimicrobial coating that could soon revolutionize indoor horticulture.

Cannabidiol "CBD" Products Lead Industrial Hemp Sales As Scientific & Clinical Studies Underscore CBD's Potential - Company Exceeds Sales as Shipping Orders Begin
PR Newswire - Wed Sep 10, 7:45AM CDT
Marijuana & Cannabis industry experiences continued growth as emerging companies develop new cannabis opportunities as a result of recent clinical studies, reports provided on latest product developments from various sector related companies: Flameret Inc. (OTC: FLRE), Cannabis Science Inc. (OTC: CBIS), Medical Marijuana Inc. (OTC: MJNA), Terra Tech Corp. (OTC: TRTC), American Green Inc. (OTC: ERBB) and Easton Pharmaceuticals Inc. (OTC: EAPH)

Medical Marijuana Inc.'s HempMeds Top Sponsor of Hope4Harper's "Run4Hope"
GlobeNewswire - Fri Sep 05, 8:46AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMeds(TM) - a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for Medical Marijuana, Inc. - is the top sponsor of Hope4Harper's 3 Annual "Run4Hope" 1 Mile Kids Fun Run & 5K takes place Saturday, September 6 at Andy Brown Park - East, 260 E. Parkway Blvd., Coppell, TX 75019.

NTRR: Feds Increase Cannabis Production as Demand Soars
Business Wire - Thu Sep 04, 4:00AM CDT
As Neutra Corp. (OTCBB:NTRR) prepares to debut revolutionary new indoor horticulture tools in a hungry marketplace, the demand for medical cannabis has grown so strong that even the federal government is increasing its production of the herb.

Enertopia Makes Steady Progress as Industry Heats Up
ACCESSWIRE - Mon Aug 25, 9:10AM CDT
WHITEFISH, MT / ACCESSWIRE / August 25, 2014 / Canada's Marihuana for Medical Purposes Regulations ("MMPR"

program has been mired in controversy since the beginning. After switching from the Medical Marihuana Access Regulations ("MMAR"

to the MMPR program in October 1, 2013, Personal Use Production Licenses ("PUPL"

and Designated Person Production Licenses ("DPPL"

were phased out on March 31, 2014.

GreenLeaf Acquisition Expands Endexx's Product Line Up
ACCESSWIRE - Mon Aug 25, 8:23AM CDT
WHITEFISH, MT / August 25, 2014 / The market for legalized marijuana in the United States is expected to surpass $8 billion by 2018, according to Marijuana Business Daily. In addition to the recreational legalization of marijuana in Colorado and Washington State, voters will have the opportunity to legalize the drug in Washington DC, Alaska and Oregon in November, which could potentially expand the market far beyond the $8 billion figure.

National Cable Documentary Features Medical Marijuana, Inc.; Educates Millions Worldwide on CBD-Rich Hemp Oil
GlobeNewswire - Mon Aug 25, 8:00AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) is honored that AWE TV selected industrial hemp-based cannabidiol (CBD) as the focal point of the third part of its popular series "Marijuana, Miracle Cure 3: Journey to Health." The latest show aired Sunday, August 24 through AWE TV's network of cable television providers reaching an audience of 16.2 million worldwide. "Journey to Health" will re-broadcast on Friday and Saturday night, Sept. 5 and 6. Check AWE's cable network for show times. AWE TV broadcasts also stream live through ROKU(TM), Boxee(TM), Samsung(TM) connected TVs, Panasonic(TM) 2011+ connected TVs and 3D content on VUDU.

NTRR: U.S. Cannabis Market Poised to Grow with November Ballots
Business Wire - Thu Aug 21, 7:31AM CDT
The U.S. cannabis market appears primed to continue its unprecedented growth this year with 17 votes on the herb scheduled for the November general election. By that time, Neutra Corp. (OTCBB: NTRR) plans to be in production on its groundbreaking new Diamond Anvil vaporizer pen.

Medical Marijuana, Inc. Portfolio Company KannaLife Sciences Covered by International Press for Signing New License With NIH to Develop Treatment for CTE Using Medicinal Marijuana
GlobeNewswire - Wed Aug 20, 8:29AM CDT
From the US to Turkey, the world is "buzzing" with the news that the National Institutes of Health, a U.S. Government Agency division of the Department of Health and Human Services, has approved KannaLife's drug discovery plan for using cannabis as the source for a new drug that will treat a concussion syndrome called Chronic Traumatic Encephalopathy or "CTE."

Medical Marijuana Inc.'s HempMeds Featured in Groundbreaking Cable TV Documentary on Cannabidiol (CBD)
GlobeNewswire - Tue Aug 19, 8:00AM CDT
Medical Marijuana Inc. (OTC Pink:MJNA) is extremely proud to announce that its subsidiary company, HempMeds(TM), is being featured in a groundbreaking documentary on industrial hemp cannabidiol (CBD) by AWE TV.

Medical Marijuana Inc. & Wellness Managed Services' MPSI Featured by Bloomberg, Lands Exclusive Seattle Hempfest Security Contract
GlobeNewswire - Thu Aug 14, 8:06AM CDT
Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that its subsidiary, Wellness Managed Services' MPS International (MPSI), was recently featured by Bloomberg and was selected to provide on-site event security services at SeattleHempfest August 15-17. Seattle Hempfest is the world's largest annual cannabis protest rally featuring six stages for music and speakers and more than 400 exhibits featuring food, arts and crafts. Admission is free and, at Seattle's 23 annual Hempfest, attendees will see a new feature: a legal recreational cannabis use area.

Looking to Invest in Unusual Businesses?
ACCESSWIRE - Thu Aug 14, 8:05AM CDT
Deerfield Beach, FL / Aug 14, 2014 / When investing in the stock market, investors generally look for companies that are in familiar businesses. Understanding a company's business model certainly makes analysis easier. However, beating the market with these stocks can generally be a challenge. That is why investors should also look at companies that are involved in unusual businesses. The main advantage of investing in such companies is that they do not face significant competition. This means that if their business model is sound they can generate significant returns and even beat the market on a consistent basis.

Organigram: The Next Publicly-Traded MMPR Licensed Producer
ACCESSWIRE - Mon Aug 11, 8:26AM CDT
WHITEFISH, MT / August 11, 2014 / The market for legalized medical marijuana in Canada is expected to generate $1.3 billion in annual revenue over the next ten years, driven by a rapidly expanding patient population under the country's new Marihuana for Medical Purposes Regulations ("MMPR"

, which was introduced earlier this year to replace the old Medical Marihuana Access Program ("MMAR"

regulations.

National Press Coverage for Medical Marijuana, Inc. -- Portfolio Company Kannalife Sciences Awarded NIH License to Develop Target Drugs to Treat Concussion Syndrome CTE Using Marijuana
GlobeNewswire - Tue Aug 05, 1:45PM CDT
Medical Marijuana, Inc. (OTC Pink: MJNA) is pleased to announce that one of its investment portfolio companies, KannaLife Sciences, Inc. ("KannaLife"

, a bio-pharmaceutical and phyto-medical company, has been awarded its second license agreement by the National Institutes of Health (NIH) to develop a drug to treat a concussion syndrome called CTE using derivatives from medical marijuana. The license agreement is in effect through February, 2021. In addition to CTE, in June 2012, KannaLife was previously awarded an exclusive license from NIH, for the same '507 Patent, for the development of a target drug candidate for treating Hepatic Encephalopathy (HE).

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...